Other reports however suggest that anti‐CSF1R inhibitor appeared to re‐educate macrophages rather than decreasing their numbers in mouse glioma, correlating with tumor size reduction (Pyonteck et al, 2013). This evidence concerns the gene CSF1R and central nervous system cancer.